News

Proteomics International awarded funding to support diabetic kidney disease test development – The Market Herald

Proteomics International (PIQ) has been awarded over $400,000 in funding to manufacture its predictive diagnostic test for diabetic kidney disease.

By being able to manufacture PromarkerD locally, Proteomics said it hoped to strengthen and diversify its supply chains and launch future tests.

Article: Proteomics International (ASX:PIQ) awarded funding to support diabetic kidney disease test development

Subscribe
  • This field is for validation purposes and should be left unchanged.